Doctoral Researcher – Turku, Finland
21.5.2026Apply by: 2 June 2026
University of Turku is seeking a Doctoral Researcher to join Professor Jukka Westermarck’s laboratory at the Turku Bioscience Centre. The PhD project focuses on the role of the PP2A inhibitor protein CIP2A and its splice variant NOCIVA in cancer biology, particularly in triple-negative breast cancer (TNBC).
The research aims to uncover how NOCIVA splicing is regulated in cancer and evaluate its potential as a biomarker and therapeutic target. The project combines molecular cancer biology, functional studies, and clinically relevant translational research in a highly international environment with strong cancer research infrastructure.
Applicants must hold an MSc degree and have documented experience in experimental cancer research using cell-based models. Preferred expertise includes CRISPR/Cas9 gene editing, viral gene transfer, bioinformatics, and gene regulation mechanisms. Strong communication and teamwork skills are essential.
The position starts in August 2026, with funding secured until April 2030. Salary is approximately €2500–2600/month initially, according to the Finnish university salary system.